What we do
Sophisticated Managers of a Life Sciences Venture Capital Fund
Pursuing a Venture Capital Strategy
Equity & Early Commercialization for the Innovative Life Science Venture
High Return Investments in the Future of Life Science and Health
Our Market Focus
Human & Veterinary Life Sciences Biotech
Investment into individual First-in-Class innovative entrepreneurial Ventures
The Opportunity
When innovators are unable to attract capital for cutting-edge technologies, discoveries with blockbuster potential never make it to market.
• Investment size is too small
• Entrepreneurs often have deep scientific knowledge but lack business acumen
• The 7–10+ year timeline to commercialize regulated products is unappealing
INVESTORS NEED
Tailored novel life science portfolio companies
Risk averse platform of energetic due diligence
Early commercialization opportunities
Pathways to expedite value creation for Founders
Exclusive IP with royalties and out licensing opportunities
Investors need the InnoCom Special Purpose Vehicle Solution to identify their Ideal Investments
-
Tailored Business Model
-
Biotech Life Sciences Portfolio Companies
-
Start-up opportunities for novel innovations
-
Value Creation and Expedited Commercialization
OUR SOLUTION
A Portfolio Investment Manager Solves The Problem
•Capital for Innovators & Founders
•De-risking by choosing a suitable portfolio investment with independent due diligence and early commercialization
•Synergies created by securing Multiple Technologies
•Business support and guidance at C-Suite and Board Level
•Licensing opportunities to access Value Creation
•Flexible Investor Exits through M & A, Trade Sales or IPO